informations à fournir par le fabricant. STANDARD. ISO. Second edition . Reference number. ISO (E). Provläsningsexemplar. ISO Implants for Surgery – Active Implantable Medical Devices – Part 1: General Requirements for Safety, Marking and for Information to be Provided. It is most important that the objectives and potential uses of an. AAMI product standard or recommended practice are clearly understood. The objectives of.
|Published (Last):||27 June 2017|
|PDF File Size:||14.46 Mb|
|ePub File Size:||17.68 Mb|
|Price:||Free* [*Free Regsitration Required]|
Safety and effectiveness questions associated with minor amendments to currently licensed implantable leads can frequently be resolved with preclinical testing alone.
This section addresses specific requirements for AIMDs intended to treat tachyarrhythmia, including implantable defibrillators. Note that the accelerated tests referenced above are designed to simulate conductor fatigue and not insulation fatigue.
In addition to device labelling, provide copies of implant registration cards in conformance with the applicable sections 66 – 68 of the Regulations. Fite Date of publication: Prior to testing, the leads or lead components are preconditioned as fully assembled and shipped product. Sleeves lso move freely on the lead body until secured, should provide adequate retention when secured, and should not damage the lead after securing the lead to tissue.
Cardiac rhythm management devices — Symbols to be used with cardiac rhythm management device labels, and information to be supplied — General requirements.
Guidance Document – Medical Device Applications for Implantable Cardiac Leads –
May Number of pages: Where claims are made regarding lead polarization, data from bench testing should be provided to support these claims. The system senses heart electrical activity and delivers therapy in the form of low energy pulses or higher isp shocks.
The maximum pressure that the lead tip can exert should be determined. Health Canada is pleased to announce the release of the final version of the Guidance Document: Both the implanted product and non-implantable supporting equipment require testing and evaluation to specific standards. As a guidance, this document represents Health Canada’s current thinking on the information needed to support an application for an investigational testing authorization, a device licence, or a licence amendment for cardiac leads.
This portion of the standard covers specific requirements for cardiac pacemakers. IEC requires compliance to IECwhich covers the application of usability engineering to medical devices. To obtain an investigational testing authorization for a device, manufacturers are referred to the guidance document entitled Preparation of an Application for Investigational Testing – Medical Devices.
It has a spelling mistake. Where new drugs that do not have substantial past clinical experience are 144708-1 into a cardiac lead, additional requirements may apply.
Active Implantable Medical Device Testing: What You Need to Know
Device failures that are detected during testing should be fully discussed. Shelf Life of Electrical and Mechanical Specifications: Additionally, a stylet should not damage the lead body after multiple insertions simulations, when using a worst-case lead configuration.
Appropriate leads, licensed in Canada, should be used as controls in studies to establish comparative threshold and sensing, comparative battery longevity and comparative fibrous tissue encapsulation for new the drug eluting lead tips.
Massive growth in OR equipment is driving the excitement of upgrading to 4K resolution in surgical displays and cameras. Testing should be carried out using the methods and test flex fixtures described and illustrated in Section Non-active surgical implants — Joint replacement implants — Specific requirements for knee-joint replacement implants.
Clinical safety indicators include adverse events and complications associated with conductor failure, extracardiac stimulation, insulation failure, low or high pacing impedance, loss of capture, sensing problems loss, over-sensing or under-sensinglead dislodgement, perforation and other lead-related adverse events, including death. Here is an overview of the different sections: To clarify the information necessary to satisfy the requirements of the Canadian Medical Devices Regulations Regulations as they pertain to an application for an investigational testing authorization, a device licence or a licence amendment for implantable cardiac leads in order to facilitate access to these therapeutic products.
Validation testing should be provided to demonstrate that values for the lead conductor resistance, pacing impedance and sensing impedance, measured in accordance with the methods described in Section 6. Any specific testing required to verify novel device features should also be performed. The housing material, if different from the insulation material, should be examined for biocompatibility and evidence of degradation.
The document provides specific guidance for bench testing, biocompatibility, biostability, animal and clinical studies of cardiac leads. Ensure that the anchoring sleeves, provided premounted or as accessories, securely attach the lead when used according to the instructions for use. The izo should include corrective activities. The testing results should be reported in a statistically meaningful format [for example e.
Lists of National Standards
Infections should be assessed by culturing and identifying pathogens. Most AIMDs consist of both the product inserted into the body and non-implantable supporting equipment, both of which require testing and evaluation to medical regulatory standards. Equivalent validation testing is required in support of adaptors. Leads should be excised and examined for biostability and structural integrity indicators including insulation degradation, bond isk and abrasion.
Information ixo outdated or wrong. Implants for surgery — Active implantable medical devices — Part 4: Evaluating the implantable and non-implantable equipment simultaneously has several advantages, including savings in time and costs, so manufacturers should consider an approach that incorporates both testing types. Pacing lead impedances should be measured.
Fatigue testing that approximates flexural stresses on lead segments at critical anatomic zones e.